Tubular breast carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Stimulant abuse
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
3
|
1
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Attention deficit-hyperactivity
|
disease |
|
Mental or Behavioral Dysfunction
|
9
|
1
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2019 |
Metabolic symptoms
|
phenotype |
|
Sign or Symptom
|
9
|
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Hyperplastic lymph node
|
disease |
|
Acquired Abnormality
|
12
|
|
0.010 |
None |
< 0.001 |
1 |
|
1991 |
1991 |
Coronary Restenosis
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
16
|
2
|
0.200 |
None |
1.000 |
1 |
|
2002 |
2002 |
Hypoadiponectinemia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
16
|
17
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Adult attention deficit hyperactivity disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
20
|
6
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Adiponectin Measurement
|
phenotype |
|
Laboratory Procedure
|
25
|
70
|
0.100 |
None |
1.000 |
5 |
7
|
2010 |
2014 |
Myomatous neoplasm
|
disease |
Neoplasms; Musculoskeletal Diseases
|
Neoplastic Process
|
25
|
|
0.010 |
None |
1.000 |
1 |
|
1988 |
1988 |
Asthma attack
|
disease |
Respiratory Tract Diseases; Immune System Diseases
|
Disease or Syndrome
|
32
|
1
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
gallbladder neoplasm
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
51
|
6
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Impulsive character (finding)
|
phenotype |
|
Mental or Behavioral Dysfunction
|
52
|
19
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Barrett Epithelium
|
disease |
Digestive System Diseases; Neoplasms
|
Disease or Syndrome
|
52
|
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
High Grade Lymphoma (neoplasm)
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
62
|
|
0.010 |
None |
1.000 |
1 |
|
1989 |
1989 |
Amphetamine Abuse
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
75
|
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Amphetamine-Related Disorders
|
group |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
78
|
3
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Amphetamine Addiction
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
81
|
2
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
granulosa cell tumor
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
88
|
5
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Zinc deficiency
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
90
|
4
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
AIDS related complex
|
disease |
Infections; Immune System Diseases
|
Disease or Syndrome
|
100
|
43
|
0.010 |
None |
< 0.001 |
1 |
|
1991 |
1991 |
Blood Pressure
|
phenotype |
|
Organism Function
|
109
|
220
|
0.100 |
None |
1.000 |
1 |
1
|
2007 |
2007 |
Organic Mental Disorders, Substance-Induced
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
115
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Non-small cell lung cancer stage I
|
disease |
|
Neoplastic Process
|
115
|
1
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Prescription Drug Abuse
|
phenotype |
Chemically-Induced Disorders; Mental Disorders
|
Finding
|
115
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |